Pfizer, Subsidiaries Fined By Indonesia For Price Fixing
This article was originally published in PharmAsia News
Executive Summary
Indonesian authorities said U.S.-based Pfizer and four of its units were guilty of price fixing in the marketing of anti-hypertension drugs